Bronchodilator effects of terbutaline and epinephrine in obstructive lung disease

Marvin A. Sackner, Ned Greeneltch, Grace Silva, Adam Wanner

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


A double-blind crossover comparison was made of the effects of terbutaline, a new adrenergic drug with major action on beta 2 receptors, epinephrine, and saline, on pulmonary function in 16 patients with chronic bronchitis or emphysema and 9 patients with bronchial asthma. Serial determinations of lung volumes, dynamic mechanics of breathing, and distribution of ventilation were made after subcutaneous administration. Terbutaline, 0.5 mg, was a more effective bronchodilator and had a longer duration of action than epinephrine 0.25 mg, but was associated with a higher incidence of side effects. These were generally minor and transient and included tremor, nervousness, and palpitations. Terbutaline may be useful in the management of bronchospasm of asthma, chronic bronchitis, and emphysema.

Original languageEnglish (US)
Pages (from-to)499-506
Number of pages8
JournalClinical Pharmacology and Therapeutics
Issue number3 PART 1
StatePublished - Sep 1974

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Bronchodilator effects of terbutaline and epinephrine in obstructive lung disease'. Together they form a unique fingerprint.

Cite this